Author

Joon Y. Park

University of California, Los AngelesORCID 0000-0002-3847-9198Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Erina VlashiiD· 1 shared Hoang DaoiD· 1 shared Joe Crompton· 1 shared Mark D. GirgisiD· 1 shared Timothy R. DonahueiD· 1 shared Tyler R. McCawiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Erina VlashiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 12, 2025

Inhibition of AXL dependent non-professional efferocytosis sensitizes pancreatic cancer to immune checkpoint blockade

Joon Y. Park, Tyler R. McCaw, Hoang Dao…·Mark D. Girgis

This study shows that inhibiting AXL in pancreatic cancer cells enhances immune checkpoint therapy by blocking non-professional efferocytosis and increasing CD8 T cell infiltration.

DOI 10.1101/2025.08.12.669943

mousebulk RNA-seq